0.00Open0.00Pre Close0 Volume0 Open Interest155.00Strike Price0.00Turnover101.12%IV-25.01%PremiumDec 20, 2024Expiry Date31.01Intrinsic Value100Multiplier8DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9188Delta0.0083Gamma3.94Leverage Ratio-0.1520Theta-0.0236Rho-3.62Eff Leverage0.0279Vega
BWX Technologies Stock Discussion
To put it simply, the nuclear energy world is undergoing a tidal shift. As you’ve read in our previous emails, amidst an ever-widening uranium supply shortfall future availability has been further tightened due to geopolitics and the isolation of Russia – a critical source of uranium and uranium fuel services. As you can see ...
$Sprott Physical Uranium Trust (U.U.CA)$ $Sprott Physical Uranium Trust (U.UN.CA)$ $Sprott Uranium Miners ETF (URNM.US)$ $SPROTT JUNIOR URANIUM MINERS ETF (URNJ.US)$ $GLOBAL X URANIUM INDEX ETF CLASS A UNITS (HURA.CA)$ $VanEck Uranium and Nuclear ETF (NLR.US)$ $VanEck Junior Gold Miners ETF (GDXJ.US)$ $Global X Uranium ETF (URA.US)$ $Mega Uranium Ltd (MGA.CA)$ $Cameco (CCJ.US)$ $Uranium Energy (UEC.US)$ $Encore Energy (EU.US)$ $BWX Technologies (BWXT.US)$ $Blue Sky Uranium Corp (BSK.CA)$ $Uranium Royalty (UROY.US)$ $Uranium Energy (UEC.US)$
Gap Ups
1. $Atlassian (TEAM.US)$ - up 15.4%
2. $Natera (NTRA.US)$ - up 10.9%
3. $Universal Display (OLED.US)$ - up 7.6%
4. $Amazon (AMZN.US)$ - up 7.3%
5. $BWX Technologies (BWXT.US)$ - up 5.7%
6. $Cloudflare (NET.US)$ - up 3.9%
7. $Booking Holdings (BKNG.US)$ - up 3.5%
8. $DaVita (DVA.US)$ - up 3...
Gap Ups
1. $Option Care Health (OPCH.US)$ - up 2.5%
2. $BWX Technologies (BWXT.US)$ - up 2.0%
3. $Crown Holdings (CCK.US)$ - up 1.6%
4. $Graphic Packaging (GPK.US)$ - up 1.5%
5. $Palo Alto Networks (PANW.US)$ - up 1.4%
Gap Downs
1. $EPAM Systems (EPAM.US)$ - down 14.5%
2. $Globant (GLOB.US)$ ...
• $Axsome Therapeutics (AXSM.US)$ +39.1% (received from FDA proposed labeling for the its AXS-05 product candidate with respect to its New Drug Application for AXS-05 for the treatment of major depressive disorder)
• $Capricor Therapeutics (CAPR.US)$ +4% (announces statistically significant clinical benefits in skeletal muscle function in non-ambulant duchenne muscular dystrophy patients treated with CAP-1002 in HOPE-2 Open L...
No comment yet